|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news of interest to hospital pharmacists, selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries; any comments regarding content of this publication should be emailed to CSHP. It should not be understood or inferred from the presence of advertisements that CSHP endorses any products or services advertised. Similarly, CSHP is not responsible for the quality of journalism reflected in the articles: it should not be understood or inferred that CSHP supports the information provided. MultiView and CSHP are not liable, any delays or inaccuracies in the information contained in this brief, nor for any actions taken or outcomes resulting from relying on the information provided herein.
In this issue:
• MERS outbreak: 3 lessons Canada learned from SARS
• Harper government takes action to improve drug control
• Health ministers urging pharmacare program to pay for prescription drugs
• Star investigation: Drug facilities allowed to self-inspect
• Drug-addicted babies on the rise in North Bay
• Health Canada issues recall for Allerject anaphylaxis medication
• Canada's public health care to see more corporate influence under TPP
MERS outbreak: 3 lessons Canada learned from SARS
As South Korea faces an outbreak of Middle East respiratory syndrome, or MERS, Canadian health officials are staying vigilant in case the virus makes it inside our borders.
It's more than a decade since severe acute respiratory syndrome, or SARS, infected 8,000 people and killed 774 around the world. Experts say that based on lessons learned from dealing with SARs, the Canadian health system is much better equipped to handle any potential outbreaks — even if the risk of MERS coming to Canada is still very low.
Harper government takes action to improve drug control
The Honourable Rona Ambrose, Minister of Health, along with Roxanne James, Parliamentary Secretary to Canada's Minister of Public Safety and Emergency Preparedness, recently announced a series of proposed enhancements to the Controlled Drugs and Substances Act (CDSA); updating Health Canada's nearly two-decade-old rules for drug control.
The CDSA has two core objectives: Protecting public health and maintaining public safety.
Health ministers urging pharmacare program to pay for prescription drugs
Canada should have a national pharmacare program to help people pay for prescription drugs, several provincial and territorial health ministers said as they vowed to make it a key issue in this fall's federal election. "Certainly I think we have an opportunity given that this is an election year federally, to put and keep this issue on the agenda," said Ontario Health Minister Eric Hoskins, who is a family physician.
Star investigation: Drug facilities allowed to self-inspect
Health Canada allows drug ingredients into the country from hundreds of pharmaceutical facilities that have not been inspected by a regulator, an ongoing Star investigation has found.
Instead, nearly 300 foreign drug facilities have been inspected only by themselves or hired consultants.
A unique online training program, developed by a team of experts and compliant with USP <797>, has just been launched by BCE Pharma. The program helps participants improve their knowledge and skills by watching videos related to compounding sterile preparations, filmed in a controlled environment. The participants also take part in online activities and quizzes to test their knowledge and answers are given in real time.
For more information call 1-514-544-5051 or visit www.bcepharma.com.
Drug-addicted babies on the rise in North Bay
North Bay has seen a major increase in the number of babies born addicted to drugs, the Nipissing and Parry Sound Children's Aid Society says.
The number has more than doubled since 2012, executive director Gisele Hébert told CBC News.
Health Canada issues recall for Allerject anaphylaxis medication
Health Canada is recalling two batches of epinephrine auto-injector products used in the treatment of serious allergic reactions in children.
The agency is says it's due to a manufacturing defect that may render the device ineffective at delivering the medication in an emergency.
Allerject, which is used in the emergency treatment of anaphylaxis, works by reversing the rapid and dangerous decrease in blood pressure and relaxing the muscles in the airway during an allergic reaction.
Hospira's vision of integrity,
accountability, and speed
makes us a leading provider
of a comprehensive line of
high quality and cost
effective generic injectables
Learn more about Hospira's speciality injectable
pharmaceuticals at www.hospira.ca or contact
your Hospira Representative at 1-866-488-6088.
Canada's public health care to see more corporate influence under TPP
Just days after a number of provincial health ministers advocated for the creation of a national pharmacare program, a leaked document suggests Canada may have to abandon any such plans if it signs up to the Trans-Pacific Partnership.
According to a draft chapter of the 12-country free trade agreement currently under negotiation, leaked by Wikileaks, Canada may also see drug prices rise as pharma companies gain more access to government decisions on pricing.
Missed last week's issue? See which articles your colleagues read most.
50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8